MY102906A - Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions - Google Patents

Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions

Info

Publication number
MY102906A
MY102906A MYPI87002010A MYPI19872010A MY102906A MY 102906 A MY102906 A MY 102906A MY PI87002010 A MYPI87002010 A MY PI87002010A MY PI19872010 A MYPI19872010 A MY PI19872010A MY 102906 A MY102906 A MY 102906A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical
ergot alkaloid
containing compositions
alkaloid containing
dihydro ergot
Prior art date
Application number
MYPI87002010A
Inventor
Zuger Othmar
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08602602A external-priority patent/GB2170407B/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY102906A publication Critical patent/MY102906A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

A CONTROLLED RELEASE FORMULATION FOR ORAL ADMINISTRATION COMPRISING - A 9, 10-DIHYDRO ERGOT ALKALOID, - A PHARMACEUTICALLY ACCEPTABLE HYDROPHILIC SWELLING SUBSTANCE AND - A PHARMACEUTICALLY ACCEPTABLE INERT FATTY MATERIAL.
MYPI87002010A 1986-02-03 1987-09-28 Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions MY102906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08602602A GB2170407B (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions

Publications (1)

Publication Number Publication Date
MY102906A true MY102906A (en) 1991-06-15

Family

ID=79730922

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002010A MY102906A (en) 1986-02-03 1987-09-28 Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions

Country Status (1)

Country Link
MY (1) MY102906A (en)

Similar Documents

Publication Publication Date Title
HK12395A (en) Formulation for preparing sustained release drugs for oral administration
AU5087290A (en) Transmembrane formulations for drug administration
AP9400645A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release sold dosage forms of medicaments prepared thereby.
IL102614A (en) Controlled release pharmaceutical composition containing verapamil and methods for the preparation thereof
FI961996A0 (en) Delayed-release formulations for 24-hour metoprolol release
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
ES8307095A1 (en) Pharmaceutical Formulation.
AU8199187A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
IL89868A (en) Pharmaceutical compositions for oral administration, based on diphosphonic acid derivatives
MY101029A (en) Bromocriptine compositions
AU5157590A (en) Pharmaceutical compositions for oral administration
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
AU2726088A (en) Ampule for controlled administration of beneficial agent
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
AU1518492A (en) Pharmaceutical compositions for transcutaneous administration
AU3756797A (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
AU2027288A (en) Erythromycin formulations for oral administration
AU2617288A (en) Pharmaceutical formulations for transdermal administration
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
ES8800040A1 (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
AU2623688A (en) Oral formulation of buspirone and salts thereof
MY102906A (en) Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
AU3041789A (en) Pharmaceutical formulations with controlled drug release